|Bid||33.910 x 3000|
|Ask||33.920 x 2700|
|Day's Range||33.660 - 33.940|
|52 Week Range||25.550 - 35.600|
|PE Ratio (TTM)||25.40|
|Dividend & Yield||1.90 (5.67%)|
|1y Target Est||N/A|
AstraZeneca plc shares rose after the company reportedly confirmed that its CEO is not quitting the company to join the generic drug-maker, Teva Pharmaceutical Industries Limited (TEVA).
Arena plans to offer and sell shares of its common stock worth $150 million, subject to customary closing conditions.